THERAPURE BIOPHARMA INC has a total of 27 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and chemical engineering are IMMUTEP, GENEXINE INC and DENMEADE SAMUEL R.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 13 | |
#2 | United States | 6 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Chemical engineering | |
#4 | Foods and drinks | |
#5 | Measurement | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Separation | |
#5 | Enzymes | |
#6 | Microorganisms | |
#7 | Analysing materials | |
#8 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Bell David | 10 |
#2 | Brookes Steven | 8 |
#3 | Adamson J Gordon | 6 |
#4 | Lihme Allan Otto Fog | 5 |
#5 | Miller David | 4 |
#6 | Bell David N | 4 |
#7 | Adamson Gord | 4 |
#8 | Seo Jin Seog | 4 |
#9 | Matthews Kathryn E | 2 |
#10 | Matthews Kathryn Emma | 2 |
Publication | Filing date | Title |
---|---|---|
EP3601331A1 | Method for purification of albumin | |
WO2017221185A1 | Hemoglobin-targeted drug delivery for the treatment of cancer | |
US2016158368A1 | Methods and compositions for the treatment of histiocytosis | |
US2013209419A1 | Methods of Engraftment | |
CA2728000A1 | Polysaccharide-protein conjugates reversibly coupled via imine bonds | |
EP1660133A1 | Targeted delivery of anti-viral compounds through hemoglobin bioconjugation |